Skip to main content
. 2023 May 20;24(10):9043. doi: 10.3390/ijms24109043

Figure 4.

Figure 4

Alterations in urinary NAG (A) and KIM-1 (B) levels at the end of the study in non-diabetic control rats and in diabetic rats treated with vehicle, metformin, canagliflozin, metformin + canagliflozin, or quercetin for a period of 12 weeks. Data are presented as mean ± SEM. # p < 0.05 vs. non-diabetic control rats and * p < 0.05 vs. vehicle-treated diabetic rats.